Kygevi (doxecitine and doxribtimine) earned FDA approval as the first treatment for thymidine kinase 2 deficiency, supported by data from a Phase II trial and multiple retrospective studies showing ...
AI in software engineering— a loose, vibes-based approach has given way to a systematic approach to managing how AI systems ...